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Abstract 
Rheumatoid arthritis (RA)-related pulmonary disorders specifically airway abnormalities and interstitial pneumonia 
(IP) are important extra-articular manifestations. The forced oscillation technique (FOT) is a useful method to assess 
respiratory impedance, respiratory resistance (Rrs) and reactance (Xrs), at different oscillatory frequencies during tidal 
breathing. The aim of this study was to characterize the respiratory mechanics of patients with RA and to relate them 
to parameters of the pulmonary function test and findings of chest CT images. Respiratory impedance of RA patients 
(n = 69) was measured as a function of frequency from 4 to 36 Hz using the FOT device and compared with that of 
healthy subjects (n = 10). Data were retrospectively reviewed. Patients were female-dominant (60.9 %) and 95.7 % 
had abnormal CT findings including airway and parenchymal abnormalities. Thirty-seven of 69 patients (53.6 %) were 
smokers. Rrs was significantly frequency-dependent in RA patients but not in the healthy subjects. Xrs were signifi-
cantly frequency-dependent in both RA and healthy groups. Rrs was significantly higher during an expiratory phase in 
both RA and healthy groups. Xrs was significantly lower (more negative) during an expiratory phase than that during 
an inspiratory phase in RA patients but not in healthy subjects. Xrs of the RA group was significantly more nega-
tive than that of the normal control. There was no difference in impedance parameters between the airway lesion 
dominant (n = 27) and IP dominant groups (n = 23) in the RA group. The impedance parameters of the RA group 
significantly correlated with most parameters of the pulmonary function test. In pulmonary function test results, % of 
the predicted value for forced expiratory flow from 25 to 75 % of forced vital capacity was significantly lower and % of 
the predicted value for diffusing capacity of the lung for carbon monoxide was higher in the airway lesion dominant 
group than those in the IP dominant group. Krebs von den Lungen-6, a serum indicator of IP, was significantly higher 
in the IP group than that in the airway lesion dominant group. Taken together, the impedance results reflect abnor-
malities in pulmonary functions and structures in patients with RA.
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Background
Rheumatoid arthritis (RA) is a systemic inflammatory 
disease associated with extra-articular diseases includ-
ing pulmonary diseases (Perez et al. 1998; Turesson et al. 
2003; Brown 2007). RA-related pulmonary disorders, 
specifically interstitial pneumonia (IP) and airway abnor-
malities, are recognized as an important extra-articular 
manifestation because they are responsible for a signifi-
cant portion of the mortality (Brown 2007; Olson et  al. 
2011; Tsuchiya et al. 2011). Computed tomography (CT) 
of the lung and pulmonary function tests have been 
used widely to manage the pulmonary abnormalities 
of patients with RA (Cortet et al. 1997; Fuld et al. 2003; 
Biederer et al. 2004; Tanaka et al. 2004; Mori et al. 2008, 
2011).
The forced oscillation technique (FOT) is an accu-
rate method to assess respiratory mechanics from input 
impedance measurements (Dubois et  al. 1956; Grimby 
et al. 1968; Michaelson et al. 1975). This method is less 
dependent on patient effort than spirometry. Another 
benefit of FOT is that it enables measurement of both 
inspiratory and expiratory parameters during tidal 
breathing (Cauberghs and Van de Woestijne 1992; Pes-
lin et  al. 1992; Dellaca et  al. 2004; Kanda et  al. 2010; 
Paredi et  al. 2010; Fujii et  al. 2015). Measurement of 
respiratory system impedance (Zrs), respiratory resist-
ance (Rrs) and reactance (Xrs), has been used success-
fully to assess respiratory functions of normal subjects 
and patients with respiratory diseases such as asthma, 
chronic obstructive pulmonary disease (COPD), and 
interstitial lung disease (van Noord et al. 1989; Dellaca 
et  al. 2004; Kanda et  al. 2010; Paredi et  al. 2010; Ohi-
shi et al. 2011; Ito et al. 2012; Miranda et al. 2013; Shi-
rai et  al. 2013; Sugiyama et  al. 2013; Fujii et  al. 2015; 
Hasegawa et  al. 2015). Rrs reflects the extent of air-
flow obstruction (Di Mango et al. 2006; Hasegawa et al. 
2015). Xrs is determined by the elastic properties of the 
respiratory system at the lowest frequency and the iner-
tive properties at higher frequencies (Oostveen et  al. 
2003). It is expected that FOT will be able to identify 
respiratory abnormalities in patients with RA that are 
not detectable by spirometric examinations (Faria et al. 
2012). However, the Zrs assessed by this technique has 
not been fully evaluated in patients with RA-related 
pulmonary diseases yet.
The purpose of the present study was to character-
ize the respiratory mechanics measured by FOT in 
patients with RA and to relate them to parameters of 
pulmonary function tests and findings of chest CT 
images. In addition, frequency-dependent and within-
breath behavior of the respiratory mechanics were also 
evaluated.
Results
Clinical characteristics and pulmonary function test results
The characteristics and laboratory and pulmonary func-
tion test results of the 69 patients with RA shown in 
Table 1. 88.2 % were positive for anti-cyclic citrullinated 
peptide (anti-CCP) antibody (≥4.5  U/ml), and 86.3  % 
were positive for rheumatoid factor (RF) (≥20.0 U/ml). 
Next, the characteristics and pulmonary function test 
results of the airway lesion predominant and IP pre-
dominant groups were compared. The predominant 
CT patterns were classified as: airway lesion predomi-
nant (n = 27, 39.1 %), IP predominant (n = 23, 33.3 %), 
mixed pattern of airway abnormalities and IP (n  =  5, 
7.2 %), other patterns (n = 11, 15.9 %), or no abnormal 
findings (n  =  3, 4.3  %). Krebs von den Lungen-6 (KL-
6), a serum indicator of IP, was significantly higher in 
the IP group than those in the airway lesion dominant 
group (Table  1). Pulmonary function test results show 
that % of the predicted value for diffusing capacity of 
the lung for carbon monoxide (%DLCO) and residual 
volume (RV)/total lung capacity (TLC) ratio were sig-
nificantly higher and % of the predicted value for forced 
expiratory flow from 25 to 75 % of forced vital capacity 
(FVC) (%FEF25–75), which reflects small airway diseases 
in RA (Mori et al. 2008; Mori et al. 2011), was lower in 
the airway lesion dominant group than that in the IP 
group (Table  1). Thirty-seven of 69 patients (53.6  %) 
were smokers, but there were no significant difference 
in smoking history between the airway lesion dominant 
and IP groups (Table 1).
CT findings
Representative CT images of airway lesion dominant and 
IP dominant patterns are shown in Additional file 1: Fig-
ure S1. The characteristics, frequency, and grades of CT 
findings in all 69 cases, airway lesion predominant group 
(n = 27), and IP predominant group (n = 23) are shown 
in Table  2. Grades and frequency of CT findings of the 
airway lesion dominant and IP dominant groups were 
compared (Table  2). Characteristic CT findings of IP 
such as ground grass opacity, reticulation, honey comb-
ing, and traction bronchiectasis were more frequent in 
the IP dominant group. On the other hand, findings of 
bronchiectasis/bronchiolectasis and bronchiolar abnor-
mality were more frequent in the airway lesion dominant 
group.
Respiratory impedance of RA
Rrs and Xrs results at a given frequency of all 69 patients 
are shown in Fig. 1. The Rrs values during a whole breath, 
inspiratory phase, and expiratory phase were significantly 
frequency-dependent (P < 0.001) and gradually decreased 
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as a function of frequency from 4 to 32 Hz but increased 
at 36  Hz (Fig.  1a). Rrs values were significantly higher 
during the expiratory phase than during the inspiratory 
phase (P < 0.001) at all frequencies (Fig. 1a). Xrs values 
during a whole breath, inspiration, and expiration were 
also significantly increased as a function of frequency 
(Fig.  1b). Expiratory Xrs values were significantly lower 
than inspiratory Xrs (P = 0.004) specifically at lower fre-
quencies (4–20 Hz) (Fig. 1b).
High prevalence (53.6 %) of smoking history in our RA 
cohort (Table 1) is an important cofounding factor. Thus, 
we compared the Zrs results of smokers (n  =  37) with 
those of never smokers (n = 32). However, there was no 
difference in Rrs or Xrs during a whole breath between 
ever and never smokers (Additional file  2: Figure S2A 
and S2B). Moreover, differences between inspiratory and 
expiratory phases (Δ) in Xrs (ΔXrs) calculated as mean 
inspiratory values minus mean expiratory values were 
not statistically significantly different between the groups 
(Additional file 2: Figure S2C).
Respiratory impedance of healthy control subjects
Next, we re-analyzed the Zrs results at a given frequency 
of the healthy control group of our previous study (age: 
24–59  years, n  =  10) (Uchida et  al. 2013). The biom-
etric and spirometric characteristics of the healthy con-
trol group are shown in Additional file  3: Table S1. Rrs 
was not significantly frequency-dependent during a 
whole breath, inspiratory phase, or expiratory phase 
(Fig.  2a) different from that in the RA group (Fig.  1a). 
Rrs values were significantly higher during the expira-
tory phase than during the inspiratory phase (P < 0.001) 
at most frequencies (Fig. 2a). Xrs values during a whole 
breath, inspiration, and expiration were also significantly 
increased as a function of frequency (Fig. 2b). There was 
no difference in Xrs between inspiratory and expiratory 
phases (Fig. 2b).
Comparison of impedance between RA and control groups
Next, we compared the Zrs results of the RA 
and healthy control groups. Rrs was significantly 
Table 1 Clinical characteristics and pulmonary function test results of investigated subjects
Values are mean ± SD. Values were compared using t-test, Chi square test, or Fisher’s exact test
Anti-CCP Ab anti-cyclic citrullinated peptide antibody, RF rheumatoid factor, KL-6 Krebs von den Lungen, a serum indicator of interstitial pneumonia, SP-D surfactant 
protein-D, FEV1 forced expiratory volume in 1 s, FVC forced vital capacity, VC vital capacity, FEF25–75 forced expiratory flow from 25 to 75 % of FVC, TLC total lung 
capacity, RV residual volume, DLCO diffusing capacity of the lung for carbon monoxide, VA alveolar volume
* Significantly different (P < 0.05) between the airway lesion dominant and IP dominant groups
Subjects Total, n = 69 Airway, n = 27 IP, n = 23 P value
Age, years (range) 65.5 ± 10.1 (39–86) 65.6 ± 9.4 (39–80) 62.5 ± 9.6 (39–78) 0.253
Sex, male/female 27/42 8/19 14/9 0.053
Height, cm 157.2 ± 10.4 155.2 ± 8.5 162.4 ± 12.1 0.016*
Weight, kg 57.9 ± 13.5 55.2 ± 12.9 62.3 ± 14.3 0.071
BMI 23.3 ± 4.6 22.9 ± 5.3 23.4 ± 3.4 0.729
Current/ex/never smokers 9/28/32 2/10/15 4/12/7 0.177
Pack-years (range) 45.8 ± 34.8 (0.8-147.0) 41.0 ± 34.2 (0.8–105.0) 47.3 ± 34.7 (1.2–147.0) 0.639
Duration of RA, years 12.5 ± 10.1 14.0 ± 9.2 8.5 ± 6.3 0.019*
Anti-CCP Ab, U/ml 187.3 ± 274.2 (n = 51) 221.6 ± 422.6 (n = 17) 222.8 ± 243.6 (n = 19) 0.936
RF, IU/ml 254.3 ± 514.7 (n = 51) 218.8 ± 445.3 (n = 19) 208.3 ± 249.6 (n = 16) 0.892
KL-6, U/ml 492.7 ± 336.2 (n = 58) 394.3 ± 270.9 (n = 22) 646.0 ± 388.7 (n = 21) 0.018*
SP-D, ng/ml 68.6 ± 31.0 (n = 19) 47.2 ± 22.3 (n = 5) 75.8 ± 29.5 (n = 10) 0.081
LDH, IU/ml 214.5 ± 44.7 218.1 ± 46.0 213.7 ± 52.1 0.750
%VC 97.6 ± 15.4 95.6 ± 16.6 95.0 ± 13.9 0.938
%FVC 99.9 ± 17.7 97.2 ± 19.6 97.9 ± 16.2 0.884
%FEV1 87.8 ± 19.1 81.8 ± 20.0 89.3 ± 19.3 0.182
FEV1/FVC, % 71.1 ± 10.3 67.9 ± 11.4 74.5 ± 7.8 0.025*
FEF25–75/FVC, % 51.9 ± 25.8 44.0 ± 25.1 62.1 ± 25.2 0.016*
%FEF25–75 52.6 ± 25.7 42.3 ± 23.1 63.1 ± 24.8 0.004*
%TLC 102.2 ± 15.3 102.9 ± 14.4 97.7 ± 16.2 0.233
%RV 100.1 ± 22.1 104.7 ± 22.0 92.5 ± 21.3 0.054
RV/TLC % 37.6 ± 7.2 39.6 ± 7.9 34.1 ± 5.0 0.006*
%DLCO 97.0 ± 22.0 104.9 ± 15.9 80.1 ± 20.0 <0.001*
%DLCO/VA 99.7 ± 26.3 107.3 ± 18.2 84.1 ± 25.8 <0.001*
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frequency-dependent in the RA group (Fig.  1a) but 
not in the healthy control group (Fig. 2a). As a results, 
there was a significant interaction in the Rrs curves 
(P  <  0.001) between group (either the RA or healthy 
control) and frequency by two-way repeated-measure 
analysis of variance (ANOVA) during a whole breath 
(Fig. 3a), inspiration, and expiration. There was no sig-
nificant difference between the groups in the mean 
values of Rrs during a whole breath (Fig.  3a), inspira-
tion, and expiration. Xrs during a whole breath of the 
RA group was significantly lower (more negative) 
(P  =  0.018) than that of the control group (Fig.  3b). 
Similarly, Xrs during inspiratory and expiratory phases 
was significantly more negative than that of the control 
group. ΔXrs was not statistically significantly different 
between the groups (Fig. 3c).
Comparison of impedance between airway lesion and IP 
dominant groups in RA
Next, we compared the Zrs results of the airway lesion 
dominant and IP dominant groups in RA patients. Dur-
ing a whole breath, inspiratory phase, and expiratory 
phase, Rrs and Xrs were significantly frequency-depend-
ent (P  <  0.001) in both groups. However, there was no 
significant difference between the groups in values of Rrs 
or Xrs (Fig. 4a, b). ΔXrs was not statistically significantly 
different either (Fig. 4c).
Correlations between impedance and pulmonary function 
test results
Correlations between parameters of the Zrs and pulmo-
nary function test are shown in Table  3. Rrs values at 
the lowest (4 Hz, R4), middle (20 Hz, R20), and highest 
Table 2 CT findings
Airway airway lesion dominant pattern, IP interstitial pneumonia dominant pattern
* Significantly different (P < 0.05) between airway lesion and IP dominant groups (Mann–Whitney test or Fisher’s exact test)
Findings, n (%) Total, n = 69 Airway, n = 27 IP, n = 23 P value
Airspace consolidation 25 (36.2 %) 15 (55.6 %) 5 (21.7 %)
Grade, median (range) 0 (0–2) 1 (0–1) 0 (0–1) 0.034*
Ground grass opacity 31 (44.9 %) 5 (18.5 %) 18 (78.3 %)
Grade, median (range) 0 (0–4) 0 (0–2) 1 (0–4) <0.001*
Reticulation 41 (59.4 %) 11 (40.7 %) 20 (87.0 %)
Grade, median (range) 1 (0–3) 0 (0–1) 1 (0–3) <0.001*
Bronchovascular bundle thickening 1 (1.4 %) 1 (3.7 %) 0
Grade, median (range) 0 (0–1) 0 (0–1) 0 (0–0) 0.377
Honeycombing 10 (14.5 %) 0 9 (39.1 %)
Grade, median (range) 0 (0–3) 0 (0–0) 0 (0–3) <0.001*
Nodules 49 (71.4 %) 26 (96.3 %) 10 (43.5 %)
Grade, median (range) 1 (0–4) 1 (0–4) 0 (0–1) <0.001*
Emphysema 20 (29.0 %) 2 (7.4 %) 13 (56.5 %)
Grade, median (range) 0 (0–3) 0 (0–2) 1 (0–3) <0.001*
Bullae 24 (34.8 %) 4 (14.8 %) 13 (56.5 %)
Grade, median (range) 0 (0–1) 0 (0–1) 1 (0–1) <0.001*
Bronchiectasis or bronchiolectasis 23 (33.3 %) 19 (70.4 %) 0
Grade, median (range) 0 (0–2) 1 (0–2) 0 (0–0) <0.001*
Traction bronchiectasis 20 (29.0 %) 3 (11.1 %) 17 (73.9 %) <0.001*
Crazy-paving appearance 2 (2.9 %) 0 2 (8.7 %) 0.207
Tree-in-bud sign 6 (8.7 %) 5 (18.5 %) 0 0.054
Architectural distortion 14 (20.3 %) 4 (14.8 %) 8 (34.8 %) 0.183
Pulmonary artery enlargement 2 (2.9 %) 0 1 (4.3 %) 0.460
Esophageal dilatation 15 (21.7 %) 4 (14.8 %) 8 (34.8 %) 0.183
Lymph node enlargement 16 (23.2 %) 6 (22.2 %) 5 (21.7 %) 1
Pleural or pericardial effusion or thickening 16 (23.2 %) 6 (22.2 %) 5 (21.7 %) 1
Bronchiolar abnormality 33 (47.8 %) 25 (92.6 %) 3 (13.0 %) <0.001*
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(36  Hz, R36) frequencies during a whole breath were 
selected for analysis. ΔXrs at low frequencies is increased 
by expiratory flow limitation in patients with COPD 
(Dellaca et al. 2004) and becomes negative in restrictive 
disorder in patients with interstitial lung diseases (Sugiy-
ama et al. 2013; Fujii et al. 2015). Therefore, Xrs and ΔXrs 
at the lowest frequency (4 Hz, X4 and ΔX4, respectively) 
were selected for analysis. ΔX4 significantly negatively 
correlated with %FVC, % of the predicted value for forced 
expiratory volume in 1  s (%FEV1), and of the predicted 
value for TLC (%TLC). Relationships between %FVC and 
ΔX4 for all cases and the IP dominant group are shown 
(Fig. 5a, b). ΔX4 also inversely correlated with  %FVC in 
the IP group alone (r = −0.426, P < 0.05, Fig. 5b).
Association between CT findings and impedance results
Next, we examined whether values of the Zrs param-
eters were affected by the existence of RA-related pul-
monary abnormalities based on CT findings. Due to rare 
prevalence (prevalence  ≤  2 in Table  2), bronchovascu-
lar bundle thickening (n =  1), crazy-paving appearance 
(n  =  2), and pulmonary artery enlargement (n  =  2) in 
CT findings were excluded for the analysis. X4 during a 
whole breath was significantly lower (more negative) in 
patients with esophageal dilatation than those without 
(−1.66 ± 1.11 cmH2O/L/s vs. −1.00 ± 1.13 cmH2O/L/s, 
Fig. 1 Frequency dependences of respiratory impedance, respiratory 
resistance (Rrs) and reactance (Xrs) at 4–36 Hz, during a whole breath, 
inspiratory phase and expiratory phase, were examined. The Rrs (a) 
and Xrs (b) of all rheumatoid arthritis (RA) cases (n = 69) are shown. 
Values during inspiratory and expiratory phases are mean ± SD 
(cmH2O/L/s). Averages of Rrs and Xrs during a whole breath are 
also shown (dashed lines). *Significant difference (P < 0.05) between 
inspiratory and expiratory phases by two-way repeated measure 
ANOVA, followed by Bonferroni test for post hoc analysis
Fig. 2 Frequency dependences of the Rrs (a) and Xrs (b) of the 
healthy subjects (n = 10) are shown. Values during inspiratory and 
expiratory phases are mean ± SD (cmH2O/L/s). Averages of Rrs and 
Xrs during a whole breath are also shown (dashed lines). *Significant 
difference (P < 0.05) between inspiratory and expiratory phases by 
two-way repeated measure ANOVA, followed by Bonferroni test for 
post hoc analysis
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P  <  0.05). ΔX4 was significantly higher in patients with 
architectural distortion than those without (1.05 ±  2.27 
cmH2O/L/s vs. 0.14 ± 0.83 cmH2O/L/s, P < 0.05). Values 
of the Rrs parameters were not significantly affected by 
the existence of either CT finding.
Discussion
The main findings of the present study were that in 
patients with RA: (1) Rrs and Xrs values were signifi-
cantly dependent on frequency and differed between 
expiratory and inspiratory phases, (2) Xrs values and fre-
quency-dependent behavior in Rrs were significantly dif-
ferent from those of the healthy subjects, (3) impedance 
parameters significantly correlated with most parameters 
of the pulmonary function test, (4) impedance results 
were not significantly different between the airway 
lesion dominant and IP dominant groups, and (5) KL-6, 
%DLCO, RV/TLC, %FEF25–75, and FEV1/FVC were sig-
nificantly different between the airway lesion dominant 
and IP dominant groups. It has been reported that KL-6 
is a useful serum marker reflecting IP specifically pulmo-
nary fibrosis including in RA-related IP (Kinoshita et al. 
2004). Parameters of the pulmonary function test such 
as %DLCO, FEV1/FVC, and %FEF25–75 have been used to 
evaluate functional impairment in pulmonary manifes-
tations associated with RA (Fuld et  al. 2003; Mori et  al. 
2008, 2011). Our findings are consistent with results of 
those previous reports. In contrast, Rrs, Xrs, or ΔXrs 
was not significantly different between the airway lesion 
dominant and IP dominant groups unexpectedly prob-
ably due to heterogeneity and large variability as one of 
characteristics of RA-related pulmonary abnormalities. 
To our knowledge, however, this is the first study to char-
acterize the respiratory impedance measured by FOT 
and relate it to pulmonary functions and CT findings in 
patients with RA-related pulmonary diseases.
One of the advantages of FOT is the ability to evalu-
ate Zrs over a range of frequencies (Dubois et  al. 1956; 
Fig. 3 Rrs (a) and Xrs (b) during a whole breath in the RA (n = 69) and healthy control groups (n = 10) are compared. c Differences between 
inspiratory and expiratory phases (Δ) in Xrs (ΔXrs) calculated as mean inspiratory values minus mean expiratory values are also compared. Values 
are mean ± SD (cmH2O/L/s). *Significant difference (P < 0.05) between inspiratory and expiratory phases by two-way repeated measure ANOVA, 
followed by Bonferroni test for post hoc analysis. #There was a significant interaction in the Rrs curves between the group (either the RA or healthy 
control) and frequency (P < 0.001)
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Grimby et al. 1968; Michaelson et al. 1975; Hantos et al. 
1992; Ito et  al. 2007; Bates et  al. 2011; Tanimura et  al. 
2014). We examined the Rrs and Xrs data at a given 
frequency between 4 and 36 Hz and found that the Rrs 
and Xrs of the RA group were significantly frequency-
dependent in all cases (Fig.  1) and airway lesion domi-
nant and IP dominant groups (Fig.  4). It is generally 
known that Xrs increases from negative values to positive 
values in a frequency-dependent manner both in healthy 
subjects and patients with respiratory diseases (Oost-
veen et al. 2003; Bates et al. 2011) as found in the present 
study. In contrast, Rrs in healthy subjects was not sig-
nificantly frequency dependent (Fig. 2). As a result, there 
was a significant interaction between the frequency and 
group when the Rrs values of RA and normal subjects 
were compared (Fig.  3a). The frequency-dependence of 
Rrs reflects the inhomogeneity in gas flow in the respira-
tory system specifically during bronchoconstriction as 
well as in patients with COPD and restrictive abnormal-
ity due to interstitial lung disease (van Noord et al. 1989; 
Pride 1992; Lutchen et  al. 1996). Taken together, the 
results suggest that the frequency-dependence in Rrs in 
medium frequency range derives from both airway and 
parenchymal abnormalities in patients with RA.
The within-breath behavior of the Zrs results showed 
that Rrs was significantly higher during the expira-
tory phase than that during the inspiratory phase in RA 
(Fig.  1a). Expiratory Xrs was slightly but significantly 
lower than inspiratory Xrs at lower frequencies in the 
RA group (Fig. 1b). However, there was no difference in 
ΔXrs between the airway lesion dominant and IP domi-
nant groups (Fig. 4c). Dellaca et al. reported that ΔXrs at 
low frequencies is beneficial for detecting expiratory flow 
limitation in patients with COPD (Dellaca et  al. 2004). 
They analyzed individual respiratory cycles and proposed 
2.8 cmH2O/L/s of ΔX5 as an optimal threshold value 
of for expiratory flow limitation (Dellaca et al. 2004). In 
contrast to their analysis, we calculated the average of 
respiratory cycles during the Zrs measurements for Δ Xrs 
analysis as reported by other groups (Kanda et al. 2010; 
Fig. 4 Rrs (a) and Xrs (b) during a whole breath in the airway lesion dominant (n = 27) and interstitial pneumonia (IP) dominant groups (n = 23) 
are shown. c ΔXrs values are also compared in the airway lesion dominant (n = 27) and IP dominant groups. Values are mean ± SD (cmH2O/L/s) 
and compared by two-way repeated measure ANOVA, followed by Bonferroni test for post hoc analysis
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Paredi et al. 2010; Mori et al. 2013; Sugiyama et al. 2013). 
In the present study, ΔX4 values were above 2.8 cmH2O/
L/s in four RA cases including two cases in the IP domi-
nant group (Fig. 5) but not in the healthy subjects. Kanda 
et  al. demonstrated that expiratory R5 was significantly 
higher than inspiratory R5, but there was no significant 
difference in ΔXrs at 5 Hz (ΔX5) between the expiratory 
and inspiratory phases in the healthy subjects (Kanda 
et al. 2010). Similarly, we also found that Rrs was higher 
during the expiratory phase, but there was no significant 
difference in Xrs between the expiratory and inspiratory 
phases in the healthy subjects (Fig. 2). Interestingly, pre-
vious studies have demonstrated that inspiratory X5 of IP 
was significantly lower than expiratory X5 different from 
the findings in COPD (Mori et al. 2013; Sugiyama et al. 
2013). In the present study, ΔX4 values of the airway 
lesion dominant and IP dominant groups were not differ-
ent (Fig. 4c), inconsistent with findings in those previous 
reports (Mori et  al. 2013; Sugiyama et  al. 2013). There 
was a weak but significant negative correlation between 
ΔX4 and %FVC or %TLC, an indicator of IP severity 
(Table 3; Fig. 5). Moreover, ΔX4 with architectural distor-
tion in the CT findings was significantly higher than that 
without. Although the origin of ΔXrs is still uncertain, 
high ΔXrs values at low frequencies may derive from 
the presence of airway abnormalities, including expira-
tory flow limitations and decreases in lung volume in our 
cohort. It has been reported that small airway abnormali-
ties are involved in RA patients even when the CT find-
ings show IP dominant patterns or normal shadow (Mori 
et al. 2011; Faria et al. 2012) different from idiopathic IP 
and other collagen vascular diseases-related IP.
Impedance parameters, R4, R20, R36, and X4, signifi-
cantly correlated with most parameters of the pulmo-
nary function test (Table  3). X4 significantly correlated 
with parameters for restrictive abnormalities (VC, %VC, 
FVC, %FVC, TLC, and %TLC), consistent with previous 
findings in IP (Fujii et  al. 2015). These findings indicate 
that X4 values may be useful to detect lung volume and 
restrictive abnormalities. However, absolute Xrs and Rrs 
Table 3 Correlation between  parameters of  impedance 
and pulmonary function tests
R4 R20 R36 X4 ΔX4
Height
 R −0.323 −0.454 −0.404 0.220 0.127
 P 0.007* <0.001* <0.001* 0.070 0.300
VC
 R −0.380 −0.429 −0.412 0.480 0.017
 P 0.001* <0.001* <0.001* <0.001* 0.892
%VC
 R −0.140 0.022 −0.044 0.497 −0.229
 P 0.251 0.859 0.717 <0.001* 0.059
FVC
 R −0.424 −0.456 −0.445 0.519 −0.032
 P <0.001* <0.001* <0.001* <0.0001* 0.7947
%FVC
 R −0.201 −0.018 −0.091 0.517 −0.312
 P 0.098 0.884 0.457 <0.001* 0.009*
FEV1
 R −0.428 −0.395 −0.418 0.506 −0.024
 P <0.001* <0.001* <0.001* <0.001* 0.847
%FEV1
 R −0.220 −0.018 0.109 0.485 −0.240
 P 0.069 0.883 0.375 <0.001* 0.047*
FEV1/FVC
 R −0.136 −0.051 −0.103 0.080 0.038
 P 0.264 0.681 0.402 0.515 0.758
FEF25–75
 R −0.299 −0.235 −0.275 0.314 −0.002
 P 0.013* 0.052 0.022* 0.009* 0.985
%FEF25–75
 R −0.176 −0.069 −0.124 0.240 −0.006
 P 0.147 0.573 0.310 0.047* 0.964
FEF25–75/FVC
 R −0.127 −0.042 −0.092 0.077 0.039
 P 0.298 0.730 0.454 0.528 0.752
TLC
 R −0.380 −0.442 −0.421 0.454 0.028
 P 0.0013* 0.0001* 0.0003* <0.001* 0.817
%TLC
 R −0.148 0.051 −0.033 0.501 −0.301
 P 0.225 0.675 0.787 <0.001* 0.012*
RV
 R −0.162 −0.227 −0.205 0.099 0.086
 P 0.183 0.061 0.091 0.416 0.481
%RV
 R −0.108 −0.012 −0.057 0.170 −0.159
 P 0.379 0.920 0.640 0.162 0.192
RV/TLC
 R 0.196 0.195 0.194 −0.370 0.079
 P 0.107 0.109 0.111 0.002* 0.518
Correlation coefficient (R) and significance (P) between parameters of 
impedance and height or pulmonary function test results. R4, R20, and 
R36, respiratory resistance (Rrs) at 4, 20, and 36 Hz during a whole breath, 
respectively; X4, respiratory reactance (Xrs) at 4 Hz during a whole breath; ΔX4, 
difference between mean inspiratory and mean expiratory phases (Δ) in Xrs 
(ΔXrs) at 4 Hz
* Statistically significant relationship (P < 0.05)
Table 3 continued
R4 R20 R36 X4 ΔX4
%DLCO
 R 0.064 0.088 0.077 −0.002 0.011
 P 0.605 0.471 0.532 0.986 0.929
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values should be evaluated carefully. It is well-known that 
Zrs values are affected by body size, specifically height, 
gender, and age, similar to those of the pulmonary func-
tion test (Oostveen et al. 2013). In our RA cohort, height 
significantly correlated with R4, R20, and R36 (Table 3). 
Although previous studies have tried to establish refer-
ence data from healthy subjects, standardized predic-
tive values have not been established yet (Oostveen et al. 
2003; Shiota et al. 2005; Oostveen et al. 2013). Moreover, 
the impedance data may vary between different FOT 
devices used for the measurements (Oostveen et al. 2013; 
Tanimura et  al. 2014). Future studies are necessary to 
establish the methodology and reference values for Zrs 
measurements.
This study has several limitations. The data were ret-
rospectively collected from RA patients with multiple 
respiratory disorders and different smoking statuses. Rel-
atively high prevalence of obstructive abnormality (FEV1/
FVC < 0.70) in the spirometry and emphysema in the CT 
findings suggests involvement of COPD. It is widely rec-
ognized that pulmonary manifestations in RA are hetero-
geneous (Tanaka et al. 2004). Although it is possible that 
a smoking history itself affects pulmonary functions and 
respiratory mechanics, pulmonary inflammation due to 
cigarette smoking is an important risk factor for devel-
oping RA specifically via anti-CCP antibody production 
(Klareskog et  al. 2006). An association between positive 
anti-CCP antibody or RF and pulmonary complications 
of RA has been proposed (Klareskog et al. 2008; Reynis-
dottir et  al. 2014). Consistent with those previous find-
ings, the prevalence of anti-CCP antibody and RF was 
relatively high (88.2 and 86.3  %, respectively), most of 
which had abnormal findings on chest CT images. There-
fore, effects of smoking cannot be ignored to understand 
clinical characteristics and pathophysiology of RA-related 
pulmonary diseases. Interestingly, there was no signifi-
cant difference in the Zrs parameters (Rrs, Xrs and ΔXrs) 
between ever and never smokers due to large variability 
(Additional file 2: Figure S2). Bronde et al. reported that 
the prevalence of COPD and asthma in RA patients was 
25 and 18 %, respectively, significantly higher than those 
without RA in a population-based study in Ontario, Can-
ada (Brode et al. 2014). Taken together, our cases involv-
ing heterogeneous pulmonary abnormalities, different 
smoking statuses, and obstructive abnormality are likely 
to reflect a real-world clinical setting of patients with RA-
related pulmonary diseases. Another limitation of the 
present study is that the healthy control subjects were not 
matched to the RA group and younger than RA patients. 
The Zrs results of our healthy subjects such as frequency-
independent behavior in Rrs and within-breath behavior 
in Xrs (Fig. 2) are adequate as normal control data con-
sistent with those in the previous reports (Kanda et  al. 
2010; Faria et al. 2012). However, prospective studies with 
a larger number of subjects including patients both with 
and without pulmonary abnormalities as well as healthy 
controls are necessary to characterize in more detail the 
respiratory impedance of RA.
Conclusion
The respiratory mechanics together with pulmonary 
functions and CT findings were characterized in patients 
with RA-related airway and parenchymal abnormalities. 
Significant frequency-dependence in the Rrs parameters 
was found in the RA patients but not in the healthy sub-
jects. It is likely that respiratory physiology of RA-related 
IP is different from those of idiopathic IP. Because imped-
ance measurements are not invasive, FOT may become a 
useful tool to evaluate alterations in respiratory functions 
in RA patients in the future.
Fig. 5 Correlations between % of the predicted value for forced vital capacity (%FVC) and ΔXrs at 4 Hz (ΔX4) in all cases (n = 69, a) and IP dominant 
group (n = 23, b)
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Methods
Subjects
Patients who met the 1987 American College of Rheu-
matology classification criteria for RA and attended the 
outpatient clinic of the Department of Respiratory Medi-
cine, Nagoya University Hospital, between July 2010 and 
November 2012 were retrospectively reviewed. Sixty-
nine patients on whom Zrs measurements, pulmonary 
function test, and CT examination had been performed 
were enrolled in this study. Healthy control data obtained 
from the hospital staff of our previous publication 
(Uchida et al. 2013) were re-analyzed for the impedance 
results (Additional file 3: Table S1).
Pulmonary function tests
After impedance measurements, spirometry was per-
formed and lung volumes were determined using com-
puterized equipment (Fudak77, Fukuda Sangyo, Tokyo, 
Japan). The following spirometric parameters, vital 
capacity, FVC, FEV1, and FEF25–75, were measured. Lung 
volumes including residual volume and TLC were meas-
ured by means of the helium dilution technique. DLCO 
and its value corrected for alveolar volume (DLCO/VA) 
were measured by the single-breath technique. Data were 
given as % of the predicted values for spirometry and 
lung volumes calculated according to the method of the 
Japanese Respiratory Society (Japanese-Respiratory-Soci-
ety 2004).
Respiratory impedance measurements
Impedance data was collected by FOT using a commer-
cially available machine (MostGraph-01; Chest M.I., 
Tokyo, Japan) that generates a broad-band waveform at 
frequencies from 4 to 36 Hz in 4 Hz steps as described 
previously (Uchida et  al. 2013). Briefly, impulse oscil-
latory signals generated by a loud speaker at intervals 
of 0.25  s were applied to the respiratory system dur-
ing tidal breathing at rest. The Zrs was calculated using 
the system computer algorithms. The Zrs was recorded 
for approximately 20 s (5–6 respiratory cycles) while the 
patients firmly supported their cheeks with their palms 
in the sitting position using a nose clip with the neck in 
a comfortable neutral posture. Upper airway artifacts 
resulting from glottal changes, air leaks, and cheek sup-
port techniques during measurements significantly affect 
the impedance results (Peslin et  al. 1985; Uchida et  al. 
2013; Bikov et  al. 2015). Therefore, such upper airway 
artifacts were carefully eliminated. Three to five techni-
cally acceptable measurements were performed as rec-
ommended in the guidelines (Oostveen et al. 2003).
Analysis of impedance results
The actual values of Rrs and Xrs at given frequencies 
between 4 and 36  Hz were analyzed in this study. Each 
impedance parameter was expressed as a mean value 
during a respiratory cycle, whole-breath, inspiration, and 
expiration. ΔXrs were calculated as mean inspiratory val-
ues minus mean expiratory values according to a method 
by Dellaca et al. (2004).
Interpretation of CT examinations
CT data were obtained using a 64-row or 16-row multi-
detector row CT (Aquilion64 or Aquilion16; Toshiba 
Medical Systems Corp., Tokyo, Japan). Patients were 
scanned in the craniocaudal direction with inspiratory 
apnea. The slice thickness and reconstruction interval 
of HRCT were 0.5-/1.0-mm and 0.5-/1.0-mm, respec-
tively, using a high-spatial frequency algorithm. Routine 
CT (5-mm slice thickness and 5-mm interval) were also 
reconstructed. Both HRCT and routine CT were avail-
able for 66 cases (95.7  %), while only routine CT was 
available for 3 (4.3  %) cases. The radiological diagnosis 
was made by an experienced thoracic radiologist (S. Iw) 
and defined based on a previous report by Tanaka et al. 
(2004). The extent of CT findings was graded subjec-
tively with a five-point scale within the whole lung field 
as follows: grade 0, the finding was absent; grade 1, the 
percentage of involvement of the lungs was between 1 
and 25  %; grade 2, the percentage of involvement was 
between 26 and 50 %; grade 3, the percentage of involve-
ment was between 51 and 75 %; and grade 4, the percent-
age of involvement was more than 76  % (Tanaka et  al. 
2004). He was blinded to the patients’ clinical informa-
tion except that all patients had RA. Then, the diagnosis 
was reviewed by chest physicians (R.S and H.A.). Each 
CT finding was categorized as one of four types: airway 
lesion dominant, IP dominant, mixed (both airway lesion 
and IP) pattern, and others (Mori et al. 2012).
Statistical analysis
Repeated-measure ANOVA followed by Bonferroni’s 
post hoc test or t test was used to evaluate the statisti-
cal significance (SigmaPlot11.0; Systat Software Inc., San 
Jose, CA). When data failed a normality test, ANOVA 
on ranks followed by a Tukey test or Mann–Whitney 
test was used. P  <  0.05 was considered statistically sig-
nificant. Correlations between valuables were analyzed 
using the Spearman’s rank or Pearson’s correlation coef-
ficient. Fisher’s exact test was used to evaluate signifi-
cance in group differences in various categories. Data 
were given as mean ± SD.
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